Xiao-Li Wei
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 3
- Peptidase Inhibition and Analysis 3
-
- Circular RNAs in diseases 2
- Co-authors
- Rui‐Hua Xu (11 shared papers)Zhao-Lei Zeng (5 shared papers)Huai‐Qiang Ju (4 shared papers)Feng-Hua Wang (5 shared papers)Yun-Xin Lu (3 shared papers)Dong-liang Chen (2 shared papers)Yuhong Li (4 shared papers)Hélène Pelicano (2 shared papers)
- Journals
- Theranostics (3 papers)Journal of Translational Medicine (1 paper)Cell Death Discovery (1 paper)Oncotarget (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiao-Li Wei
12 papers receiving 662 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 326
- Oncology 221
- Molecular Biology 393
- Immunology 90
- Pathology and Forensic Medicine 61
Countries citing papers authored by Xiao-Li Wei
This map shows the geographic impact of Xiao-Li Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Li Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Li Wei more than expected).
Fields of papers citing papers by Xiao-Li Wei
This network shows the impact of papers produced by Xiao-Li Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Li Wei. The network helps show where Xiao-Li Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Li Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 245 | |
| 2 | 2019 | 100 | |
| 3 | 2016 | 75 | |
| 4 | 2013 | 52 | |
| 5 | 2014 | 47 | |
| 6 | 2015 | 36 | |
| 7 | 2013 | 34 | |
| 8 | 2016 | 24 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 15 | |
| 11 | 2014 | 13 | |
| 12 | 2018 | 11 |
About Xiao-Li Wei
Xiao-Li Wei is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 12 papers that have together received 668 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Peptidase Inhibition and Analysis (3 papers), MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers), Gastric Cancer Management and Outcomes (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (326 citations), Oncology (221 citations), Molecular Biology (393 citations), Immunology (90 citations) and Pathology and Forensic Medicine (61 citations). Xiao-Li Wei has collaborated with scholars based in China and United States. Frequent co-authors include Rui‐Hua Xu, Zhao-Lei Zeng, Huai‐Qiang Ju, Feng-Hua Wang, Yun-Xin Lu, Dong-liang Chen, Yuhong Li, Hélène Pelicano, Hui Luo and Paul J. Chiao. Their work appears in journals such as Theranostics, Journal of Translational Medicine, Cell Death Discovery, Oncotarget and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.